mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
6e-17 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
5e-15 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-12 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-12 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-12 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
7e-12 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-12 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-11 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-11 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-11 |